developed polymer micelles to deliver TLR7 agonist R837 and doxorubicin to TAMs and tumor cells for enhanced chemo-immunotherapy against breast cancer, showcasing a novel approach in nanomedicine development (83). Here, TLR7 is linked to breast carcinoma.